EFNB2 acts as a oncogene in pancreatic ductal adenocarcinoma (PDAC) and is markedly upregulated in PDAC and correlated to clinical stage and Ki67 expression levels in PDAC [36, 37]. This evidence concerns the gene MKI67 and pancreatic ductal adenocarcinoma.